We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+2.64%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+258.3%
AUM
$884M
AUM Growth
+$6.79M
Cap. Flow
-$8.89M
Cap. Flow %
-1.01%
Top 10 Hldgs %
21.23%
Holding
269
New
8
Increased
62
Reduced
115
Closed
6

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$2.95M
2
AMZN icon
Amazon
AMZN
+$2.94M
3
TEL icon
TE Connectivity
TEL
+$2.39M
4
V icon
Visa
V
+$1.47M
5
AMT icon
American Tower
AMT
+$1M

Top Sells

Rank Stock Value
1
PH icon
Parker-Hannifin
PH
+$6.62M
2
ORCL icon
Oracle
ORCL
+$5.59M
3
MON
Monsanto Co
MON
+$2.64M
4
XOM icon
ExxonMobil
XOM
+$1.85M
5
GE icon
GE Aerospace
GE
+$1.45M

Sector Composition

Rank Sector Weight
1 Healthcare 16.41%
2 Technology 15.55%
3 Industrials 11.64%
4 Consumer Staples 8.49%
5 Financials 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVO
101
Novo Nordisk
NVO
$199B
$2.21M 0.25%
95,618
– –
GLW icon
102
Corning
GLW
$139B
$2.17M 0.25%
78,932
-2,979
-4% -$82.3K
VTI icon
103
Vanguard Morningstar Total Stock Market ETF
VTI
$680B
$2.17M 0.25%
15,454
+30
+0.2% +$4.18K
VEA icon
104
Vanguard FTSE Developed Markets ETF
VEA
$234B
$2.11M 0.24%
49,096
-200
-0.4% -$8.92K
IFF icon
105
International Flavors & Fragrances
IFF
$21.8B
$2.1M 0.24%
16,976
+4,461
+36% +$583K
HOLX
106
DELISTED
Hologic
HOLX
$2.1M 0.24%
52,775
-7,350
-12% -$283K
DEO icon
107
Diageo
DEO
$51.9B
$2.08M 0.23%
14,408
-525
-4% -$75.2K
T icon
108
AT&T
T
$161B
$2.01M 0.23%
82,735
+8,534
+12% +$214K
NVS icon
109
Novartis
NVS
$293B
$2M 0.23%
29,572
-1,467
-5% -$101K
AMGN icon
110
Amgen
AMGN
$218B
$1.99M 0.23%
10,775
-395
-4% -$69.9K
NTRS icon
111
Northern Trust
NTRS
$33.6B
$1.92M 0.22%
18,701
+126
+0.7% +$13.3K
AXP icon
112
American Express
AXP
$234B
$1.91M 0.22%
19,476
-150
-0.8% -$14.7K
CB icon
113
Chubb
CB
$136B
$1.85M 0.21%
14,543
-57
-0.4% -$7.57K
MDLZ icon
114
Mondelez International
MDLZ
$80.1B
$1.77M 0.2%
43,160
+513
+1% +$20.6K
RTX icon
115
RTX Corp
RTX
$298B
$1.75M 0.2%
22,230
-1,128
-5% -$88.3K
ITW icon
116
Illinois Tool Works
ITW
$84.8B
$1.73M 0.2%
12,510
– –
ADI icon
117
Analog Devices
ADI
$186B
$1.72M 0.19%
17,943
+3,055
+21% +$288K
WELL icon
118
Welltower
WELL
$169B
$1.69M 0.19%
26,991
-8,300
-24% -$463K
XYL icon
119
Xylem
XYL
$28.3B
$1.66M 0.19%
24,626
+7,425
+43% +$539K
K
120
DELISTED
Kellanova
K
$1.66M 0.19%
25,235
-298
-1% -$17.7K
VV icon
121
Vanguard Morningstar Large-Cap ETF
VV
$54B
$1.58M 0.18%
12,682
-2,872
-18% -$357K
QCOM icon
122
Qualcomm
QCOM
$169B
$1.49M 0.17%
26,518
-305
-1% -$17K
HON icon
123
Honeywell
HON
$76.9B
$1.48M 0.17%
11,381
– –
STX icon
124
Seagate
STX
$196B
$1.47M 0.17%
26,000
– –
VIG icon
125
Vanguard Dividend Appreciation ETF
VIG
$114B
$1.44M 0.16%
14,164
+75
+0.5% +$7.64K
3 4
5
6 7

Similar funds

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
JFGLC
Johnson Financial Group LLC (Colorado) Denver, Colorado $1.5B AUM 16.09% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
SCM
SG Capital Management Chicago, Illinois $1.51B AUM 49.98% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
RCW
Rheos Capital Works Tokyo, Japan $1.5B AUM 47.78% 1-Year Est. Return
SGM
Seven Grand Managers Bronxville, New York $1.5B AUM 57.16% 1-Year Est. Return

Boston Family Office's Q2 2018 Portfolio in Review

As of Q2 2018, Boston Family Office held 269 positions worth $884M, up 0.77% from $877M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Boston Family Office's Q2 2018 filing shows 8 new, 62 increased, 115 reduced and 6 closed positions. Its largest new stake was State Street SPDR S&P Biotech ETF: 32,150 shares worth $3.06M. The largest sale was Parker-Hannifin, an estimated $6.62M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.

  • Boston Family Office's largest Q2 2018 buy was State Street SPDR S&P Biotech ETF: 32,150 shares worth $3.06M.
  • Boston Family Office added most to Amazon in Q2 2018, an estimated $2.94M increase.
  • Boston Family Office's biggest Q2 2018 reduction was Parker-Hannifin, cutting an estimated $6.62M.
  • Boston Family Office fully exited Monsanto Co in Q2 2018, selling an estimated $2.64M.
  • Boston Family Office's ten largest holdings make up 21% of its $884M portfolio in Q2 2018.
  • Boston Family Office opened 8 new positions and closed 6 in Q2 2018.
  • Boston Family Office's portfolio value rose 0.77% quarter-over-quarter to $884M.

Based on Boston Family Office's 13F filing for Q2 2018, filed 26 Jul 2018.